[1]
Soda, R. et al. 2001. Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. Acta Dermato-Venereologica. 81, 3 (May 2001), 207–208. DOI:https://doi.org/10.1080/000155501750376339.